IFU
HAE icon

iSAM Funds (UK)’s Haemonetics HAE Stock Holding History

iSAM Funds (UK)’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9,549
Closed -$712K – 706
2025
Q2 		$712K Buy
9,549
+5,917
+163% +$392K 0.16% 205
2025
Q1 		$231K Buy
+3,632
New +$247K 0.11% 284
2024
Q4 		– Sell
-2,534
Closed -$204K – 320
2024
Q3 		$204K Buy
+2,534
New +$205K 0.12% 271

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

iSAM Funds (UK)'s HAE Position: Q3 2025 in Review

iSAM Funds (UK) sold out of Haemonetics (HAE) in Q3 2025, closing a stake of 9,549 shares — an estimated $712K sold.

iSAM Funds (UK) first reported a position in HAE in Q3 2024 and held it in 3 quarters. The position peaked at $712K in Q2 2025. 301 funds tracked by Wall St. Rank hold HAE as of Q3 2025.

  • iSAM Funds (UK) reported no remaining Haemonetics position as of Q3 2025 after selling out during the quarter.
  • iSAM Funds (UK) sold 9,549 Haemonetics shares in Q3 2025, an estimated $712K.
  • iSAM Funds (UK) first reported a position in Haemonetics in Q3 2024 and held it in 3 quarters.
  • iSAM Funds (UK)'s Haemonetics position peaked at $712K in Q2 2025.
  • 301 funds tracked by Wall St. Rank held Haemonetics as of Q3 2025.

Based on iSAM Funds (UK)'s 13F filing for Q3 2025, filed 14 Nov 2025.